+ND Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Blade TherapeuticsJun 2016SEC filingmedium confidence
BiotechSouth San Francisco, US
Cameron Wheeler(Director)Elaine Jones(Director)Wendye Robbins(Executive Officer, Director)William Slattery(Director)James Scopa(Director)
BoardLuke Evnin(Director)
Board seatPeter Van Vlasselaer· per SEC Form D · $50M raise · filed Oct 2019
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.